4D Molecular Therapeutics Competitors and Similar CompaniesClear all

4D Molecular Therapeutics's competitors and similar companies include Cimeio, Vertex Pharmaceuticals, Intellia Therapeutics and Affymetrix.

	4D Molecular Therapeutics 4D Molecular Therapeutics is a company focused on creation of gene therapy products to cure genetic diseases.	Cimeio Cimeio Therapeutics is a company developing proprietary cell-shielding technology and immunotherapies to treat diseases.	Vertex Pharmaceuticals Vertex Pharmaceuticals is a biotechnology company that focuses on discovering, developing, and producing medicines.	Intellia Therapeutics Intellia Therapeutics is a genome editing company that caters to the biotechnology industry.	Affymetrix Affymetrix is a company engaged in microarray technology and genomics analysis.
Founding Date	Founding Date 2013	Founding Date 2020	Founding Date 1989	Founding Date 2014	Founding Date 1994
Type	Type Public	Type Private	Type Public	Type Public	Type Subsidiary
Tags	Tags Healthcare biotech clinical research genetics surgical solutions	Tags Healthcare biotech genetics pharma therapy	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech clinical research healthtech	Tags Healthcare biotech clinical research genetics
Locations	Locations Emeryville, US HQ	Locations Basel, CH HQ	Locations Boston, US HQ St Leonards, AU Wien, AT Bruxelles, BE São Paulo, BR Toronto, CA Praha, CZ see more	Locations Cambridge, US HQ	Locations Santa Clara, US HQ
Employees	Employees 22754% increase	Employees 21	Employees 5,40013% increase	Employees 40323% decrease	Employees 429
Valuation ($)	Valuation ($) 426.2 m	Valuation ($) N/A	Valuation ($) 121.4 b	Valuation ($) 1.7 b	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) $85.2m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) $12b (FY, 2025)	Revenue (est.) $67.7m (FY, 2025)	Revenue (est.) N/A
Net income	Net income ($140.1m) (FY, 2025)	Net income N/A	Net income N/A	Net income ($412.7m) (FY, 2025)	Net income N/A
Funding
Total funding raised	Total funding raised $ 100m	Total funding raised $ 50m	Total funding raised $ 2.4m	Total funding raised N/A	Total funding raised N/A